Members of the Muenzer MPS Research & Treatment Center recently participated in the 18th International Symposium on Mucopolysaccharidoses and Related Lysosomal Diseases (IMPSN), held June 4–7, 2026, in Florence, Italy. The symposium brought together researchers, clinicians, industry leaders, patient advocates, and families from around the world to discuss the latest advances in MPS research, treatment, and patient care.
International meetings such as IMPSN play an important role in ensuring that discoveries made in laboratories and clinics are shared across the global MPS community. By participating in these discussions, MPS Center faculty and staff remain informed about the latest scientific developments and are able to bring new knowledge, perspectives, and best practices back to the patients and families they serve.
Representing the MPS Center were Leigh Anne Weisenfeld, MSW, LCSW; Lindsay Torrice, MSN, CPNP-PC; and Dr. Monika Williams, who joined colleagues from across the global MPS community to share knowledge, foster collaborations, and explore emerging developments in the field.
During the symposium, Lindsay Torrice presented her research, “A Novel Locus-Specific GUSB Variant Database to Improve Diagnosis and Disease Severity Prediction in Mucopolysaccharidosis VII,” highlighting efforts to improve diagnostic accuracy and better predict disease severity for individuals affected by MPS VII.
Participation in international scientific meetings such as IMPSN provides valuable opportunities for MPS Center faculty and staff to engage with experts from around the world, learn about emerging research and therapies, and strengthen collaborations that advance care for individuals and families affected by MPS.
In addition to attending scientific sessions, the MPS Center team engaged with researchers, clinicians, industry partners, and patient advocates from around the world to discuss emerging therapies, newborn screening initiatives, long-term patient outcomes, and ongoing clinical research. These conversations provide valuable opportunities to exchange ideas, learn from international experiences, and identify new collaborations that can help advance care for individuals living with MPS and related lysosomal disorders.
The Muenzer MPS Research & Treatment Center remains committed to supporting research, education, and clinical excellence while contributing to the global effort to improve outcomes for those living with MPS and related lysosomal disorders.